Skip to main content
. 2011 Dec 3;49(1):58–65. doi: 10.1136/jmedgenet-2011-100174

Table 3.

Associations with TDS and its sub-phenotypes, TGCC, cryptorchidism, hypospadias and infertility for the top markers in the discovery stage and for replicated markers

Gene Marker Phase Risk allele OR (95% CI)
TDS TGCC Cryptorchidism Hypospadias Infertility
KITLG rs1352947 Discovery T 1.56 (1.18 to 1.97) 2.74 (1.82 to 4.26) 1.08 (0.77 to 1.55) 1.00 (0.52 to 2.11) 1.26 (0.86 to 1.90)
Replication 1.93 (1.39 to 2.69) 2.23 (1.55 to 3.28) 1.38 (0.89 to 2.24) na na
TGFBR3 rs12082710 Discovery T 1.77 (1.33 to 2.36) 1.55 (1.07 to 2.23) 1.62 (1.07 to 2.44) 2.04 (0.90 to 4.56) 2.38 (1.54 to 3.70)
Replication 1.52 (1.08 to 2.15) 1.49 (1.04 to 2.14) 1.64 (0.99 to 2.71) na na
BMP7 rs388286 Discovery C 1.36 (1.11 to 1.67) 1.38 (1.06 to 1.79) 1.49 (1.11 to 2.01) 1.24 (0.70 to 2.22) 1.21 (0.89 to 1.66)
Replication 1.28 (1.01 to 1.62) 1.37 (1.06 to 1.78) 1.09 (0.78 to 1.52) na na
HOXDx rs17198432 Discovery A 2.58 (1.82 to 3.70) 2.85 (1.86 to 4.38) 2.9 (1.81 to 4.63) 2.83 (1.11 to 6.64) 1.76 (1.01 to 3.01)
Replication 0.97 (0.64 to 1.48) 0.96 (0.61 to 1.50) 1.00 (0.52 to 1.83) na na

na, these phenotypes were not assessed in the replication stage.

TGCC, testicular germ cell cancer; TDS, testicular dysgenesis syndrome.